BRAF and colorectal carcinoma: Because of the above mentioned prognostic and predictive implications, the molecular profiling of RAS (KRAS and NRAS) and BRAF genes and the assessment of Mismatch Repair (MMR)/MSI status has now been added into the main CRC diagnostic and therapeutic algorithms [32].